Abstract:Immunotherapy has shown great promise for the treatment of cancer. However, the limited efficacy of single‐agent immunotherapy hinders its widespread application, which stimulated the investigation of combination therapy with improved efficacy. Herein, a tri‐functional immunostimulatory supramolecular nanomedicine consisting of indoximod (IND, an indoleamine 2,3‐dioxygenase (IDO) inhibitor), DPPA‐1 (a D‐peptide antagonist against programmed cell death ligand‐1 (PD‐L1)), and a self‐assembling D‐tetrapeptide of GDFDFDY (a powerful adjuvant with immunostimulatory properties) is reported. The resulting IND‐GDFDFDY‐DPPA‐1 behaves as a supramolecular “trident,” and its three functional parts play parallel roles to boost the effective immune responses. It is shown that the supramolecular “trident” exhibits a stronger binding ability to PD‐L1 than the DPPA‐1 peptide (>fourfold) and is able to inhibit the IDO‐1 pathway more efficiently than IND itself. The supramolecular “trident” activates and recruits the cytotoxic CD8+ T lymphocytes along with other immune effector cells in tumors, concomitant with downregulation of Foxp3+ T cells and upregulation of tumor immune‐related cytokines, thus showing a strong ability to improve the tumor microenvironment and enhance immunotherapeutic effects to prevent tumor growth and metastasis in the breast tumor model. The findings may stimulate the development of self‐assembling peptide‐based multifunctional nanomedicines for cancer therapy. A tri‐functional immunostimulatory supramolecular nanomedicine, bearing the IDO inhibitor, PD‐L1 blockade, and assembling tetra‐peptide immune adjuvant is developed and applied for cancer immunotherapy. It significantly improves the tumor microenvironments and thus shows a superior capacity to inhibit tumor growth.

A “three musketeers” tactic for inclining interferon-γ as a comrade-in-arm to reinforce the synergistic-tumoricidal therapy

Bimetallic Peroxide-Based Nanotherapeutics for Immunometabolic Intervention and Induction of Immunogenic Cell Death to Augment Cancer Immunotherapy

Intratumoral Injection of Interferon Gamma Promotes the Efficacy of Anti-Pd1 Treatment in Colorectal Cancer

Combination of GNRs-PEI/cGAMP-laden Macrophages-Based Photothermal Induced in Situ Tumor Vaccines and Immune Checkpoint Blockade for Synergistic Anti-Tumor Immunotherapy.

Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy

Efficiently restoring the tumoricidal immunity against resistant malignancies via an immune nanomodulator

Strengthening the Combinational Immunotherapy from Modulating the Tumor Inflammatory Environment via Hypoxia-Responsive Nanogels

Biomimetic "gemini nanoimmunoregulators" orchestrated for boosted photoimmunotherapy by spatiotemporally modulating PD-L1 and tumor-associated macrophages

Reigniting the cancer-immunity cycle with nanoparticles for simultaneous delivery of oncolytic peptides and a TLR agonist

Triple-Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo-Immunotherapy in Preclinical Cancer Models

Synergistic immunotherapy with a calcium-based nanoinducer: evoking pyroptosis and remodeling tumor-associated macrophages for enhanced antitumor immune response

Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy.

A Supramolecular “Trident” for Cancer Immunotherapy

Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors.

Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity

Plasmon‐Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway

Immuno‐nanozymes Mediated Synergistic Chemodynamic/Immuno‐therapy with Potentiated Anti‐tumor Efficacy

Four Birds with One Stone: A Multifunctional Polypeptide Nanocomposite to Unify Ferroptosis, Nitric Oxide, and Photothermia for Amplifying Antitumor Immunity

Cancer cell membrane–encapsulated biomimetic nanoparticles for tumor immuno-photothermal therapy

Precision Delivery of Dual Immune Inhibitors Loaded Nanomodulator to Reverse Immune Suppression for Combinational Photothermal-Immunotherapy